134 related articles for article (PubMed ID: 16813747)
1. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.
Anderson FD; Gibbons W; Portman D
Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747
[TBL] [Abstract][Full Text] [Related]
2. A look at the long-term safety of an extended-regimen OC.
Davis MG; Reape KZ; Hait H
J Fam Pract; 2010 May; 59(5):E3. PubMed ID: 20544040
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
Anderson FD; Gibbons W; Portman D
Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
[TBL] [Abstract][Full Text] [Related]
4. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
Coffee AL; Sulak PJ; Kuehl TJ
Contraception; 2007 Jun; 75(6):444-9. PubMed ID: 17519150
[TBL] [Abstract][Full Text] [Related]
5. Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen.
Anderson FD; Hait H; Hsiu J; Thompson-Graves AL; Wilborn WH; Williams RF
Contraception; 2005 Jan; 71(1):55-9. PubMed ID: 15639074
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized study of an extended cycle oral contraceptive.
Anderson FD; Hait H
Contraception; 2003 Aug; 68(2):89-96. PubMed ID: 12954519
[TBL] [Abstract][Full Text] [Related]
7. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
Kaunitz AM; Portman DJ; Hait H; Reape KZ
Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles)--an open-label, prospective, noncontrolled, office-based Phase III study.
Zahradnik HP; Hanjalic-Beck A
Contraception; 2008 May; 77(5):337-43. PubMed ID: 18402849
[TBL] [Abstract][Full Text] [Related]
9. A clinical study of transdermal contraceptive patch in Thai adolescence women.
Piyasirisilp R; Taneepanichskul S
J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
Sulak PJ; Kuehl TJ; Coffee A; Willis S
Am J Obstet Gynecol; 2006 Oct; 195(4):935-41. PubMed ID: 16647684
[TBL] [Abstract][Full Text] [Related]
11. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
[TBL] [Abstract][Full Text] [Related]
12. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
Barbosa IC; Filho CI; Faggion D; Baracat EC
Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
14. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
Bruni V; Pontello V; Luisi S; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
[TBL] [Abstract][Full Text] [Related]
15. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial.
Miller L; Notter KM
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):771-8. PubMed ID: 11704167
[TBL] [Abstract][Full Text] [Related]
16. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
Sulak P; Willis S; Kuehl T; Coffee A; Clark J
Headache; 2007 Jan; 47(1):27-37. PubMed ID: 17355491
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
Coffee AL; Kuehl TJ; Willis S; Sulak PJ
Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Nakajima ST; Archer DF; Ellman H
Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
[TBL] [Abstract][Full Text] [Related]
19. Lybrel--a continuous oral contraceptive.
Med Lett Drugs Ther; 2007 Jul; 49(1266):61-2. PubMed ID: 17652998
[No Abstract] [Full Text] [Related]
20. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
Westhoff C; Osborne LM; Schafer JE; Morroni C
Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
